Logo image of QK

Q&K INTERNATIONAL GROUP-ADR (QK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:QK - US74738J2015 - ADR

2.74 USD
+0.03 (+1.11%)
Last: 9/23/2022, 8:23:17 PM
Fundamental Rating

1

QK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. QK has a bad profitability rating. Also its financial health evaluation is rather negative. QK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QK had negative earnings in the past year.
QK Yearly Net Income VS EBIT VS OCF VS FCFQK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 0 -500M -1B -1.5B

1.2 Ratios

Industry RankSector Rank
ROA -150.72%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QK Yearly ROA, ROE, ROICQK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 0 50 -50 -100 -150

1.3 Margins

Industry RankSector Rank
OM -16.4%
PM (TTM) -54.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QK Yearly Profit, Operating, Gross MarginsQK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

QK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QK has more shares outstanding
The debt/assets ratio for QK is higher compared to a year ago.
QK Yearly Shares OutstandingQK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 200M 400M 600M 800M
QK Yearly Total Debt VS Total AssetsQK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -23.54, we must say that QK is in the distress zone and has some risk of bankruptcy.
QK has a Debt/Equity ratio of -0.21. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.21
Debt/FCF N/A
Altman-Z -23.54
ROIC/WACCN/A
WACC5.7%
QK Yearly LT Debt VS Equity VS FCFQK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 -1B -2B

2.3 Liquidity

A Current Ratio of 0.08 indicates that QK may have some problems paying its short term obligations.
QK has a Quick Ratio of 0.08. This is a bad value and indicates that QK is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
QK Yearly Current Assets VS Current LiabilitesQK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.20% over the past year.
QK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.22%.
The Revenue has been growing by 18.66% on average over the past years. This is quite good.
EPS 1Y (TTM)66.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.95%
Revenue 1Y (TTM)-14.22%
Revenue growth 3Y5.2%
Revenue growth 5Y18.66%
Sales Q2Q%-27.52%

3.2 Future

QK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.43% yearly.
QK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 54.10% yearly.
EPS Next Y98.3%
EPS Next 2Y40.48%
EPS Next 3Y25.43%
EPS Next 5YN/A
Revenue Next Year49.39%
Revenue Next 2Y52.34%
Revenue Next 3Y54.1%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QK Yearly Revenue VS EstimatesQK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
QK Yearly EPS VS EstimatesQK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QK Price Earnings VS Forward Price EarningsQK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -45.17
QK Per share dataQK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as QK's earnings are expected to grow with 25.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.48%
EPS Next 3Y25.43%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Q&K INTERNATIONAL GROUP-ADR

NASDAQ:QK (9/23/2022, 8:23:17 PM)

2.74

+0.03 (+1.11%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)10-11 2022-10-11/bmo
Inst Owners0.01%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap474.61M
Revenue(TTM)1.04B
Net Income(TTM)-569.17M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -45.17
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.84
BVpS-2.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -150.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -16.4%
PM (TTM) -54.93%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.74
Health
Industry RankSector Rank
Debt/Equity -0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -23.54
F-Score4
WACC5.7%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.95%
EPS Next Y98.3%
EPS Next 2Y40.48%
EPS Next 3Y25.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.22%
Revenue growth 3Y5.2%
Revenue growth 5Y18.66%
Sales Q2Q%-27.52%
Revenue Next Year49.39%
Revenue Next 2Y52.34%
Revenue Next 3Y54.1%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Q&K INTERNATIONAL GROUP-ADR / QK FAQ

What is the ChartMill fundamental rating of Q&K INTERNATIONAL GROUP-ADR (QK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to QK.


What is the valuation status for QK stock?

ChartMill assigns a valuation rating of 0 / 10 to Q&K INTERNATIONAL GROUP-ADR (QK). This can be considered as Overvalued.


What is the profitability of QK stock?

Q&K INTERNATIONAL GROUP-ADR (QK) has a profitability rating of 1 / 10.


What is the financial health of Q&K INTERNATIONAL GROUP-ADR (QK) stock?

The financial health rating of Q&K INTERNATIONAL GROUP-ADR (QK) is 1 / 10.